Conference Coverage

Large-scale psoriasis study links trauma to arthritis


 

References

The research was performed by researchers at the University of Iceland (Reykjavik) in collaboration with researchers at Harvard Medical School in Boston and the University of Pennsylvania in Philadelphia. It was partially funded by the Icelandic Centre for Research (RANNIS) and the National Institutes of Health. Dr. Love’s associate, Dr. Stefan Thorarensen of the division of public health at the University of Iceland, presented the findings during the clinical science session at the congress.

Dr. Love and his coauthors reported having no financial disclosures.

Pages

Recommended Reading

Ixekizumab met psoriasis endpoints by week 12, with durable response at 60 weeks
Psoriatic Arthritis Resource Center
Apremilast meets psoriasis endpoints at week 32
Psoriatic Arthritis Resource Center
BSR: Multiple benefits seen with intensive psoriatic arthritis therapy
Psoriatic Arthritis Resource Center
Anti-TNFs help psoriatic arthritis patients get back to work
Psoriatic Arthritis Resource Center
WCD: Tofacitinib’s benefits for psoriasis persist for 2 years
Psoriatic Arthritis Resource Center
VIDEO: EULAR updates cardiovascular-disease risk recommendations
Psoriatic Arthritis Resource Center
WCD: Ustekinumab succeeds as switch agent in psoriasis
Psoriatic Arthritis Resource Center
VIDEO: Predicting anti-TNF failure in psoriatic arthritis
Psoriatic Arthritis Resource Center
EULAR: Epigenetics points to anti-TNF efficacy in psoriatic arthritis
Psoriatic Arthritis Resource Center
WCD: Psoriasis plus depression magnifies MI risk
Psoriatic Arthritis Resource Center